Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Childhood-onset schizophrenia is a rare but severe form of the disorder that is often treatment-refractory. In this study, the efficacy and adverse effects of clozapine and haloperidol were compared for children and adolescents with early-onset schizophrenia. METHODS: Twenty-one patients (mean [+/-SD] age, 14.0 +/- 2.3 years) with onset of Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition-defined schizophrenia that began by age 12 years and who had been nonresponsive to typical neuroleptics participated in the study. Patients were randomized to a 6-week double-blind parallel comparison of clozapine (mean [+/-SD] final dose, 176 +/- 149 mg/d), or haloperidol, (16 +/- 8 mg/d). RESULTS: Clozapine was superior to haloperidol on all measures of psychosis (P = .04-.002). Positive and negative symptoms of schizophrenia improved. However, neutropenia and seizures were major concerns. To date, one third of the group has discontinued using clozapine. CONCLUSIONS: Clozapine has striking superiority for positive and negative symptoms in treatment-refractory childhood-onset schizophrenia. However, due to possibly increased toxic effects in this pediatric population, close monitoring for adverse events is essential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These medications remain of major importance, including clozapine, the most effective (and toxic) of all for childhood psychosis (46,47).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [46]
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Clozapine-induced agranulocytosis. incidence and risk factors in the united states
Alvir, J. M. J., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L., & Schaaf, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290303 · Cited by 967
Benes, F. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950060041004 · Cited by 744
Breier, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270051007 · Cited by 626
BUNNEY, W. E. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720150090010 · Cited by 480
Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.1.20 · Cited by 388
Pickar, D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820050009001 · Cited by 354
Cited by
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
Chakos, M., Lieberman, J., Hoffman, E., Bradford, D., & Sheitman, B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.518 · Cited by 631
Siskind, D., McCartney, L., Goldschlager, R., & Kisely, S. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.177261 · Cited by 601
National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.679 · Cited by 591
Sikich, L., Frazier, J. A., McClellan, J., Findling, R. L., Vitiello, B., Ritz, L., Ambler, D., Puglia, M., Maloney, A. E., Michael, E., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050756 · Cited by 478
Siskind, D., Siskind, V., & Kisely, S. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717718167 · Cited by 391
Rapoport, J. L., Giedd, J. N., Blumenthal, J., Hamburger, S., Jeffries, N., Fernandez, T., Nicolson, R., Bedwell, J., Lenane, M., Zijdenbos, A., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.7.649 · Cited by 388
Effective Treatment for Mental Disorders in Children and Adolescents
Burns, B. J., Hoagwood, K., & Mrazek, P. J. (1999) · Clinical Child and Family Psychology Review · doi:10.1023/a:1021826216025 · Cited by 385
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia
McClellan, J., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.02.008 · Cited by 361
Wahlbeck, K., Cheine, M., Essali, A., & Adams, C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.990 · Cited by 357
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guide, Falkai, P., Wobrock, T., Lieberman, J., et al. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500483177 · Cited by 331
Clozapine versus typical neuroleptic medication for schizophrenia
Essali, A., Al-Haj Haasan, N., Li, C., & Rathbone, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000059.pub2 · Cited by 329
Sikich, L., Hamer, R. M., Bashford, R. A., Sheitman, B. B., & Lieberman, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300327 · Cited by 308
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part II
PAPPADOPULOS, E., MACINTYRE, J. C., CRISMON, M. L., FINDLING, R. L., MALONE, R. P., DERIVAN, A., SCHOOLER, N., SIKICH, L., GREENHILL, L., SCHUR, S. B., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200302000-00008 · Cited by 289
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guidelines for Schizophrenia, Falkai, P., Wobrock, T., Lieberman, J., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030090 · Cited by 269
Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
CORRELL, C. U. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815b5cb1 · Cited by 254
Maayan, L., & Correll, C. U. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0015 · Cited by 252
Childhood-Onset Schizophrenia: Progressive Ventricular Change During Adolescence
Rapoport, J. L. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220013002 · Cited by 249
Self-citationChildhood-Onset Schizophrenia: A Double-Blind, Randomized Clozapine-Olanzapine Comparison
Shaw, P., Sporn, A., Gogtay, N., Overman, G. P., Greenstein, D., Gochman, P., Tossell, J. W., Lenane, M., & Rapoport, J. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.721 · Cited by 225
Kumra, S., Kranzler, H., Gerbino-Rosen, G., Kester, H. M., DeThomas, C., Kafantaris, V., Correll, C. U., & Kane, J. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.043 · Cited by 223
Self-citationFraguas, D., Correll, C. U., Merchán-Naranjo, J., Rapado-Castro, M., Parellada, M., Moreno, C., & Arango, C. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.07.002 · Cited by 209
Breier, A. F., Malhotra, A. K., Su, T.-P., Pinals, D. A., Elman, I., Adler, C. M., Lafargue, R. T., Clifton, A., & Pickar, D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.294 · Cited by 208
Cohen, D., Bonnot, O., Bodeau, N., Consoli, A., & Laurent, C. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182549259 · Cited by 203
Rendleman, R., & Walkup, J. T. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00049-4 · Cited by 196
Pringsheim, T., Panagiotopoulos, C., Davidson, J., Ho, J., & The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guideline group (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.9.581 · Cited by 192
Kumra, S., Oberstar, J. V., Sikich, L., Findling, R. L., McClellan, J. M., Vinogradov, S., & Charles Schulz, S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm109 · Cited by 186
Self-citationCorrell, C. U., Penzner, J. B., Parikh, U. H., Mughal, T., Javed, T., Carbon, M., & Malhotra, A. K. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.08.007 · Cited by 184
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52002-9.00013-9 · Cited by 166
Progressive Reduction of Temporal Lobe Structures in Childhood-Onset Schizophrenia
Jacobsen, L. K., Giedd, J. N., Castellanos, F. X., Vaituzis, A. C., Hamburger, S. D., Kumra, S., Lenane, M. C., & Rapoport, J. L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.678 · Cited by 185
Self-citationEfficacy and Effectiveness of Child and Adolescent Psychotherapy and Pharmacotherapy
Weisz, J. R., & Jensen, P. S. (1999) · Mental Health Services Research · doi:10.1023/a:1022321812352 · Cited by 178
Kryzhanovskaya, L., Schulz, S. C., Mcdougle, C., Frazier, J., Dittmann, R., Robertson-Plouch, C., Bauer, T., Xu, W., Wang, W., Carlson, J., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181900404 · Cited by 168
Cortical Brain Development in Nonpsychotic Siblings of Patients With Childhood-Onset Schizophrenia
Gogtay, N., Greenstein, D., Lenane, M., Clasen, L., Sharp, W., Gochman, P., Butler, P., Evans, A., & Rapoport, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.772 · Cited by 163
Jacobsen, L. K., & Rapoport, J. L. (1998) · Journal of Child Psychology and Psychiatry · doi:10.1017/s002196309700173x · Cited by 159
Atypical antipsychotics: are some more atypical than others?
Remington, G. J., & Kapur, S. (2000) · Psychopharmacology · doi:10.1007/s002130050017 · Cited by 154
Krause, M., Zhu, Y., Huhn, M., Schneider-Thoma, J., Bighelli, I., Chaimani, A., & Leucht, S. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.03.008 · Cited by 146
Second-Generation Antipsychotic Medications in Children and Adolescents
Cheng-Shannon, J., McGough, J. J., Pataki, C., & McCracken, J. T. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.372 · Cited by 152
Amygdala enlargement in dysthymia—a volumetric study of patients with temporal lobe epilepsy
van Elst, L. T., Woermann, F. G., Lemieux, L., & Trimble, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00212-7 · Cited by 161
Schur, S. B., Sikich, L., Findling, R. L., Malone, R. P., Crismon, M. L., Derivan, A., MacIntyre, J. C., Pappadopulos, E. A., Greenhill, L. L., Schooler, N. R., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200302000-00007 · Cited by 168
Childhood onset schizophrenia: cortical brain abnormalities as young adults
Greenstein, D., Lerch, J., Shaw, P., Clasen, L., Giedd, J., Gochman, P., Rapoport, J., & Gogtay, N. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01658.x · Cited by 148
Haas, M., Unis, A. S., Armenteros, J. L., Copenhaver, M. D., Quiroz, J. A., & Kushner, S. F. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0144 · Cited by 148
Gogtay, N., Sporn, A., Clasen, L. S., Nugent, T. F., Greenstein, D., Nicolson, R., Giedd, J. N., Lenane, M., Gochman, P., Evans, A., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.17 · Cited by 145
Clozapine versus typical neuroleptic medication for schizophrenia
Wahlbeck, K., Cheine, M. V., & Essali, A. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000059 · Cited by 131
Quantitative Morphology of the Cerebellum and Fourth Ventricle in Childhood-Onset Schizophrenia
Jacobsen, L. K., Giedd, J. N., Berquin, P. C., Krain, A. L., Hamburger, S. D., Kumra, S., & Rapoport, J. L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1663 · Cited by 142
Self-citationEvidence-Based Treatments in Child and Adolescent Psychiatry: An Inventory
McClellan, J., & WERRY, J. S. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200312000-00005 · Cited by 149
Pringsheim, T. M., Lam, D., Ching, H., & Patten, S. B. (2011) · Drug Safety · doi:10.2165/11592020-000000000-00000 · Cited by 151
High rate of disease-related copy number variations in childhood onset schizophrenia
Ahn, K., Gotay, N., Andersen, T. M., Anvari, A. A., Gochman, P., Lee, Y., Sanders, S., Guha, S., Darvasi, A., Glessner, J. T., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.59 · Cited by 132
Childhood‐Onset Schizophrenia: An Open‐Label Study of Olanzapine in Adolescents
Kumra, S., Jacobsen, L. K., Lenane, M., Karp, B. I., Frazier, J. A., Smith, A. K., Bedwell, J. S., Lee, P. C., Malanga, C. J., HAMBURGER, S., et al. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199804000-00015 · Cited by 134
Self-citationPractice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia
McClellan, J., & WERRY, J. S. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107001-00002 · Cited by 141
Miller, D. D., Andreasen, N. C., OʼLeary, D. S., Watkins, G. L., Ponto, L. L. B., & Hichwa, R. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01001-5 · Cited by 137
Childhood-Onset Schizophrenia: Premorbid and Prodromal Diagnostic and Treatment Histories
SCHAEFFER, J. L., & Ross, R. G. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200205000-00011 · Cited by 123
Use of antipsychotics in children and adolescents.
Findling, R. L., Steiner, H., & Weller, E. B. (2005) · PubMed · Cited by 134
Annotation: Childhood‐onset schizophrenia: clinical and treatment issues
Asarnow, J. R., Tompson, M. C., & McGrath, E. P. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00213.x · Cited by 134
Berman, R. A., Gotts, S. J., McAdams, H. M., Greenstein, D. K., Lalonde, F. M., CLASEN, L. S., Watsky, R. E., Shora, L., Ordóñez, A. E., Raznahan, A., et al. (2015) · Brain · doi:10.1093/brain/awv306 · Cited by 119
Montgomery, J. H., Byerly, M., Carmody, T. J., Li, B., Miller, D. R., Varghese, F. P., & Holland, R. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.09.002 · Cited by 127
Burchard, J. D., Bruns, E. J., & Burchard, S. N. (2002) · Community Treatment for Youth · doi:10.1093/acprof:oso/9780195134575.003.0004 · Cited by 113
Mizuno, Y., McCutcheon, R. A., Brugger, S. P., & Howes, O. D. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0577-3 · Cited by 125
Stigler, K. A., Potenza, M. N., Posey, D. J., & McDougle, C. J. (2004) · Pediatric Drugs · doi:10.2165/00148581-200406010-00003 · Cited by 114
Antipsychotics in Children and Adolescents
CAMPBELL, M., RAPOPORT, J. L., & SIMPSON, G. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00015 · Cited by 113
Self-citationAntipsychotics for Children and Young Adults: A Comparative Effectiveness Review
Seida, J. C., Schouten, J. R., Boylan, K., Newton, A. S., Mousavi, S. S., Beaith, A., Vandermeer, B., Dryden, D. M., & Carrey, N. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2158 · Cited by 110
Schneider, C., Corrigall, R., Hayes, D., Kyriakopoulos, M., & Frangou, S. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.08.001 · Cited by 108
A Profitable Conjunction: From Science to Service in Children’s Mental Health
Hoagwood, K., Burns, B. J., & Weisz, J. R. (2002) · Community Treatment for Youth · doi:10.1093/acprof:oso/9780195134575.003.0014 · Cited by 110
Clozapine in Adolescent Inpatients with Acute Mania
Masi, G., Mucci, M., & Millepiedi, S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760219135 · Cited by 109
Japanese Society of Neuropsychopharmacology (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12193 · Cited by 117
Connor, D. F., Boone, R. T., Steingard, R. J., Lopez, I. D., & Melloni, R. H. (2003) · Journal of Emotional and Behavioral Disorders · doi:10.1177/10634266030110030301 · Cited by 99
SPORN, A. L., VERMANI, A., GREENSTEIN, D. K., BOBB, A. J., SPENCER, E. P., CLASEN, L. S., TOSSELL, J. W., STAYER, C. C., GOCHMAN, P. A., LENANE, M. C., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31812eed10 · Cited by 107
Jensen, P. S., Buitelaar, J. K., Pandina, G., Binder, C. E., & Haas, M. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0580-1 · Cited by 115
Open Trial of Risperidone in 24 Young Children With Pervasive Developmental Disorders
Masi, G., Cosenza, A., Mucci, M., & Brovedani, P. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200110000-00015 · Cited by 106
ZUDDAS, A., DI MARTINO, A., MUGLIA, P., & CIANCHETTI, C. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2000.10.79 · Cited by 105
SCHIMMELMANN, B. G., Schmidt, S. J., Carbon, M., & Correll, C. U. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835dcc2a · Cited by 97
Management of Schizophrenia in Children and Adolescents: Focus on Pharmacotherapy
Masi, G., & Liboni, F. (2011) · Drugs · doi:10.2165/11585350-000000000-00000 · Cited by 105
Safety and Pharmacokinetics of Atypical Antipsychotics in Children and Adolescents
Caccia, S. (2013) · Pediatric Drugs · doi:10.1007/s40272-013-0024-6 · Cited by 99
Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS): Rationale, Design, and Methods
McCLELLAN, J., SIKICH, L., FINDLING, R. L., FRAZIER, J. A., VITIELLO, B., HLASTALA, S. A., WILLIAMS, E., AMBLER, D., HUNT-HARRISON, T., MALONEY, A. E., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180691779 · Cited by 90
“In two studies of treatment-refractory childhoodonset schizophrenia, clozapine was more beneficial than haloperidol for positive and negative symptoms (n = 21; Kumra et al., 1996) and superior to olanzapine for negative symptoms (n = 25; Shaw et al.”
BackgroundChildren with Schizophrenia: Clinical Picture and Pharmacological Treatment
Masi, G., Mucci, M., & Pari, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620100-00005 · Cited by 106
Pringsheim, T. M., Lam, D., & Patten, S. B. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0145 · Cited by 100
Gornick, M. C., Addington, A. M., Sporn, A. L., Gogtay, N., GREENSTEIN, D. K., Lenane, M., Gochman, P., Ordóñez, A. E., Balkissoon, R., Vakkalanka, R., et al. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-005-0028-3 · Cited by 91
Epileptogenic drugs: a systematic review
Ruffmann, C., Bogliun, G., & Beghi, E. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.4.575 · Cited by 83
Antipsychotics in pediatric and adolescent patients: A review of comparative safety data
Amor, L. B. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.030 · Cited by 83
Clinical relevance of findings in trials of antipsychotics: systematic review
Lepping, P., Sambhi, R. S., Whittington, R., Lane, S., & Poole, R. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.075366 · Cited by 80
Chamberlain, P. (2002) · Community Treatment for Youth · doi:10.1093/acprof:oso/9780195134575.003.0006 · Cited by 79
A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics
Lee, E. S., Vidal, C., & Findling, R. L. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0037 · Cited by 85
Clozapine for the treatment of schizophrenia
Fakra, É., & Azorin, J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.709235 · Cited by 90
Greenstein, D., Malley, J. D., Weisinger, B., Clasen, L., & Gogtay, N. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00053 · Cited by 75
Myles, N., Myles, H., Xia, S., Large, M. M. B., Bird, R. J., Galletly, C. A., Kisely, S. R., & Siskind, D. J. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419833166 · Cited by 84
Lewis, R. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804300608 · Cited by 92
Common polygenic variation and risk for childhood-onset schizophrenia
Ahn, K., An, S. S., Shugart, Y. Y., & Rapoport, J. L. (2016) · Molecular Psychiatry · doi:10.1038/mp.2014.158 · Cited by 74
Olanzapine compared to quetiapine in adolescents with a first psychotic episode
Arango, C., Robles, O., Parellada, M., Fraguas, D., Ruíz-Sancho, A., Medina, Ó., Zabala, A., Bombín, I., & Moreno, D. M. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0749-5 · Cited by 78
Refractory schizophrenia and atypical antipsychotics
Taylor, D. M., Taylor, D. M., & Duncan-McConnell, D. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400411 · Cited by 78
Clozapine Pharmacokinetics in Children and Adolescents with Childhood-Onset Schizophrenia
Frazier, J. A., Cohen, L. G., Jacobsen, L. K., Grothe, D. R., Flood, J. G., Baldessarini, R. J., Piscitelli, S. C., Kim, G. S., & Rapoport, J. L. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00012 · Cited by 77
Antipsychotics in early onset Schizophrenia: Systematic review and meta-analysis
Armenteros, J. L., & Davies, M. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-005-0515-2 · Cited by 86
Moncrieff, J. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.183.2.161 · Cited by 75
Alfaro, C. L., Wudarsky, M., Nicolson, R., Gochman, P., Sporn, A., Lenane, M., & Rapoport, J. L. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760219126 · Cited by 73
Atypical neuroleptics in child and adolescent psychiatry
Remschmidt, H., Hennighausen, K., Heiset, P., Clement, W., & Schulz, E. (2000) · European Child & Adolescent Psychiatry · doi:10.1007/s007870070015 · Cited by 73
Metabolic side effects of atypical antipsychotics in children: a literature review
Fedorowicz, V. J., & Fombonne, E. J. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105056543 · Cited by 81
Toren, P., Ratner, S., Laor, N., & Weizman, A. (2004) · Drug Safety · doi:10.2165/00002018-200427140-00005 · Cited by 75
Atypical antipsychotics for psychosis in adolescents
Kumar, A., Datta, S. S., Wright, S., Furtado, V. A., & Russell, P. S. S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009582.pub2 · Cited by 75
Kumra, S., Kranzler, H. N., Gerbino-Rosen, G., Kester, H. M., DeThomas, C., Cullen, K., Regan, J., & Kane, J. M. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0089 · Cited by 69
Self-citationCastro‐Fornieles, J., Parellada, M., Soutullo, C. A., Baeza, I., González-Pinto, A. M., Graell, M., Payá, B., Moreno, D. M., de la Serna, E., & Arango, C. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0138 · Cited by 77
Gogtay, N., Sporn, A. L., CLASEN, L. S., GREENSTEIN, D. K., Giedd, J. N., Lenane, M., Gochman, P., Zijdenbos, A. P., & Rapoport, J. L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.569 · Cited by 69
Autonomic Nervous System Markers of Psychopathology in Childhood-Onset Schizophrenia
Zahn, T. P. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220020003 · Cited by 68
Metadata
- Authors
- Kumra, S.
- Affiliations
- National Institute of Mental Health (US)
- Corresponding author
- Kumra, Sanjiv
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1996-12-01
- Volume
- 53
- Issue
- 12
- Pages
- 1090
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2125778283
- Cited by
- 410
- References
- 53
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 2 · 2021: 8 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 3 · 2016: 13 · 2015: 5 · 2014: 7 · 2013: 19 · 2012: 23
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- childhood schizophrenia, clozapine, haloperidol, treatment-resistant schizophrenia, antipsychotic efficacy, adverse drug reactions, neutropenia, seizures, positive and negative symptoms, child psychiatry, atypical antipsychotics
- MeSH terms
- Adolescent, Age Factors, Child, Child, Preschool, Clozapine, Double-Blind Method, Drug Administration Schedule, Haloperidol, Humans, Neutropenia, Psychiatric Status Rating Scales, Schizophrenia, Childhood, Seizures, Severity of Illness Index, Treatment Outcome, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.